Novo Nordisk A/S (NVO)
36.66
-1.10
(-2.91%)
USD |
NYSE |
Mar 03, 16:00
37.90
+1.24
(+3.38%)
Pre-Market: 08:13
Novo Nordisk Total Liabilities (Quarterly) : 54.85B for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ascendis Pharma A/S | 1.721B |
| Evaxion AS | 14.90M |
| Regeneron Pharmaceuticals, Inc. | 9.302B |
| Viking Therapeutics, Inc. | 76.67M |
| DBV Technologies SA | 57.64M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 85.37B |
| Shareholders Equity (Quarterly) | 30.51B |
| Debt to Equity Ratio | 0.6749 |
| Current Ratio | 0.7996 |
| Net Debt Paydown Yield | -1.07% |